ArcticZymes Technologies ASA

OB:AZT Stock Report

Market Cap: NOK 695.6m

ArcticZymes Technologies Past Earnings Performance

Past criteria checks 2/6

ArcticZymes Technologies's earnings have been declining at an average annual rate of -9%, while the Biotechs industry saw earnings growing at 7.7% annually. Revenues have been growing at an average rate of 10% per year. ArcticZymes Technologies's return on equity is 1.5%, and it has net margins of 4.2%.

Key information

-9.0%

Earnings growth rate

-9.6%

EPS growth rate

Biotechs Industry Growth20.9%
Revenue growth rate10.0%
Return on equity1.5%
Net Margin4.2%
Next Earnings Update13 Feb 2025

Recent past performance updates

ArcticZymes Technologies' (OB:AZT) Solid Earnings May Rest On Weak Foundations

Aug 30
ArcticZymes Technologies' (OB:AZT) Solid Earnings May Rest On Weak Foundations

ArcticZymes Technologies' (OB:AZT) Shareholders Have More To Worry About Than Only Soft Earnings

Feb 08
ArcticZymes Technologies' (OB:AZT) Shareholders Have More To Worry About Than Only Soft Earnings

Recent updates

Take Care Before Jumping Onto ArcticZymes Technologies ASA (OB:AZT) Even Though It's 25% Cheaper

Nov 28
Take Care Before Jumping Onto ArcticZymes Technologies ASA (OB:AZT) Even Though It's 25% Cheaper

Analysts Are More Bearish On ArcticZymes Technologies ASA (OB:AZT) Than They Used To Be

Nov 12
Analysts Are More Bearish On ArcticZymes Technologies ASA (OB:AZT) Than They Used To Be

ArcticZymes Technologies ASA Just Missed Earnings With A Surprise Loss - Here Are Analysts Latest Forecasts

Nov 09
ArcticZymes Technologies ASA Just Missed Earnings With A Surprise Loss - Here Are Analysts Latest Forecasts

The Price Is Right For ArcticZymes Technologies ASA (OB:AZT) Even After Diving 28%

Aug 31
The Price Is Right For ArcticZymes Technologies ASA (OB:AZT) Even After Diving 28%

ArcticZymes Technologies' (OB:AZT) Solid Earnings May Rest On Weak Foundations

Aug 30
ArcticZymes Technologies' (OB:AZT) Solid Earnings May Rest On Weak Foundations

ArcticZymes Technologies ASA Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Aug 25
ArcticZymes Technologies ASA Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Earnings Miss: ArcticZymes Technologies ASA Missed EPS By 17% And Analysts Are Revising Their Forecasts

May 12
Earnings Miss: ArcticZymes Technologies ASA Missed EPS By 17% And Analysts Are Revising Their Forecasts

ArcticZymes Technologies' (OB:AZT) Shareholders Have More To Worry About Than Only Soft Earnings

Feb 08
ArcticZymes Technologies' (OB:AZT) Shareholders Have More To Worry About Than Only Soft Earnings

ArcticZymes Technologies ASA Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Feb 04
ArcticZymes Technologies ASA Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Investors Aren't Buying ArcticZymes Technologies ASA's (OB:AZT) Revenues

Feb 02
Investors Aren't Buying ArcticZymes Technologies ASA's (OB:AZT) Revenues

ArcticZymes Technologies ASA's (OB:AZT) Sole Analyst Just Made A Substantial Upgrade To Their Forecasts

Apr 29
ArcticZymes Technologies ASA's (OB:AZT) Sole Analyst Just Made A Substantial Upgrade To Their Forecasts

Downgrade: Here's How This Analyst Sees ArcticZymes Technologies ASA (OB:AZT) Performing In The Near Term

Apr 15
Downgrade: Here's How This Analyst Sees ArcticZymes Technologies ASA (OB:AZT) Performing In The Near Term

One Analyst Just Shaved Their ArcticZymes Technologies ASA (OB:AZT) Forecasts Dramatically

Jan 13
One Analyst Just Shaved Their ArcticZymes Technologies ASA (OB:AZT) Forecasts Dramatically

Here's What Analysts Are Forecasting For ArcticZymes Technologies ASA (OB:AZT) After Its First-Quarter Results

May 01
Here's What Analysts Are Forecasting For ArcticZymes Technologies ASA (OB:AZT) After Its First-Quarter Results

Revenue & Expenses Breakdown

How ArcticZymes Technologies makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

OB:AZT Revenue, expenses and earnings (NOK Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 241115640
30 Jun 2411815630
31 Mar 2411818630
31 Dec 2312019610
30 Sep 2311920600
30 Jun 2311816640
31 Mar 2312017630
31 Dec 2213833610
30 Sep 2215047590
30 Jun 2214752520
31 Mar 2213948520
31 Dec 2113146480
30 Sep 2111468450
30 Jun 2110867430
31 Mar 2112084370
31 Dec 209874350
30 Sep 206443270
30 Jun 206837290
31 Mar 20888460
31 Dec 1949-1340
30 Sep 1980-9490
30 Jun 1979-10470
31 Mar 1973-13470
31 Dec 1873-14460
30 Sep 1870-20490
30 Jun 1863-27500
31 Mar 1869-27510
31 Dec 1773-25520
30 Sep 1774-26590
30 Jun 1780-24580
31 Mar 1779-21570
31 Dec 1679-20570
30 Sep 1678-20530
30 Jun 1672-19510
31 Mar 1666-18490
31 Dec 1559-17470
30 Sep 1555-15420
30 Jun 1548-16410
31 Mar 1546-18390
31 Dec 1438-22380
30 Sep 1434-23380
30 Jun 1431-21370
31 Mar 1426-24370
31 Dec 1328-23380

Quality Earnings: AZT has high quality earnings.

Growing Profit Margin: AZT's current net profit margins (4.2%) are lower than last year (16.7%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: AZT has become profitable over the past 5 years, growing earnings by -9% per year.

Accelerating Growth: AZT's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: AZT had negative earnings growth (-76.7%) over the past year, making it difficult to compare to the Biotechs industry average (-18.2%).


Return on Equity

High ROE: AZT's Return on Equity (1.5%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/19 03:47
End of Day Share Price 2024/12/19 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

ArcticZymes Technologies ASA is covered by 8 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Hans BohnBeringer Finance AB
Mikkel Nyholt-SmedsengCarnegie Investment Bank AB
Espen JørgensenDNB Markets